Nature

Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities

In this study, we aimed to explore the utility of chromosomal microarray analysis (CMA) in groups of pregnancies with a priori low risk for detection of submicroscopic chromosome abnormalities, ...
Nature

“What does it mean?”: Uncertainties in understanding results of chromosomal microarray testing

The increased sensitivity of chromosomal microarray (CMA) technology as compared with traditional cytogenetic analysis allows for improved detection of genomic alterations. However, there is potential ...
EurekAlert!

New prenatal test, chromosomal microarray, proposed as standard of care

New York, NY—A large, multi-center clinical trial led by researchers from Columbia University Medical Center (CUMC) shows that a new genetic test resulted in significantly more clinically relevant ...
ascopubs.org

Validation of a microarray-based gene expression test for tumors with uncertain origins using formalin-fixed paraffin-embedded (FFPE) specimens

The critical role of surgical pathology in personalized medicine: The impact of biopsy cavities in breast cancer samples on recurrence risk when assessed by quantitative RT-PCR ...
Scientific Research Publishing

An Autoantibody Based Protein Microarray Blood Test to Enhance the Specificity of a Negative Screening Mammogram ()

1 Kaplan Medical Center, Rehovot, Israel. 2 Eventus Diagnostics (Israel) LTD, Ora, Israel. 3 University of Texas, MD Anderson Cancer Center, Houston, USA. 4 Media Pharma Srl, Chieti, Italy. 5 ...
360dx

PathogenDx Plans Microarray-Based UTI Test as Focus Remains on Clinical Market

NEW YORK – After having cut its teeth on the cannabis, food, and COVID-19 testing markets, PathogenDx is poised to launch a microarray-based test for urinary tract infections later this year. The new ...